Sort
51,593 grants matching “hepatitis”
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease
$431,433Pooja Jain · Drexel University · R01 · FY2021 · NS
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease
$431,433Pooja Jain · Drexel University · R01 · FY2019 · NS
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease
$431,433Pooja Jain · Drexel University · R01 · FY2020 · NS
Regulation of host innate and adaptive immunity by bacterial type III effectors
$431,414James B Bliska · Dartmouth College · R01 · FY2023 · AI
Mechanisms Used by NKT Cells in the Control of Liver Tumors
$431,351Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
ONTOGENY OF HEPATIC ION TRANSPORT
$431,335Mount Sinai School Of Medicine Of Nyu · R37 · FY2002 · HD
Randomized Trial of an HIV Navigation Program for Early Palliative Care
$431,322Jacquelyn Slomka · Case Western Reserve University · R01 · FY2012 · NR
Mechanistic enzymology of quinolinic acid biosynthesis
$431,275Tadhg P. Begley · Cornell University · R01 · FY2007 · GM
Mechanism Of Interferon Induction By The Hepatitis C Virus
$431,168Francis Vincent Chisari · University Of Washington · U19 · FY2013 · AI
Impact of host protein dynamics on picornavirus RNA 5â noncoding region functions
$431,165Bert L. Semler · University Of California-Irvine · R01 · FY2018 · AI
Regulation of Hepatic Insulin Extraction
$431,102Washington University · R37 · FY2003 · DK
HCV Replication and Immune Response in HIV Coinfection
$430,973University Of Washington · R01 · FY2004 · AI
Southern California Research Center for ALPD and Cirrhosis
$430,973Hidekazu Tsukamoto · University Of Southern California · P50 · FY2024 · AA
Novel therapy targeting refractory colon cancer
$430,907Ping-Ying Pan · Methodist Hospital Research Institute · R01 · FY2017 · CA
Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics
$430,818Athena F Zuppa · Children'S Hosp Of Philadelphia · R01 · FY2012 · HL
Tuberous Sclerosis-Pathway and Pathogenesis
$430,816David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2008 · CA
Regulation of host innate and adaptive immunity by bacterial type III effectors
$430,790James B Bliska · Dartmouth College · R01 · FY2024 · AI
Mechanisms for SIV evasion of vaccine immunity: Role of FasL-mediated cell death
$430,779Charles David Pauza · University Of Maryland Baltimore · R01 · FY2007 · AI
CDPH OA 2011-2015 National HIV Behavioral Surveillance System and Hepatitis Testi
$430,759Karen Elizabeth Mark · California Department Of Public Health · U1B · FY2011 · PS
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
$430,721Samuel Klein · Washington University · R01 · FY2008 · DK
Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa
$430,683Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2013 · HL
HIV and Drug Use in Georgian Women
$430,663Hendree E. Jones · Research Triangle Institute · R01 · FY2010 · DA
CARD14 is essential for hepatitis C virus replication and activation of NFKB
$430,650Timothy L Tellinghuisen · Scripps Florida · R01 · FY2012 · DK
CARD14 is essential for hepatitis C virus replication and activation of NFKB
$430,650Timothy L Tellinghuisen · Scripps Florida · R01 · FY2014 · DK
CARD14 is essential for hepatitis C virus replication and activation of NFKB
$430,650Timothy L Tellinghuisen · Scripps Florida · R01 · FY2015 · DK